Understanding Therapeutic Pathways and Comorbidities in Psoriasis
Psoriasis is now recognized as an immunologically mediated systemic disease that may be expressed in cutaneous and joint symptoms.
Natural History, Presentation, and Diagnosis of Hidradenitis Suppurativa
The diagnosis of hidradenitis suppurativa (HS) is a clinical one based on characteristic history and physical exam. No confirmatory laboratory tests exist, and although histologic features can support the diagnosis or rule out alternate diagnoses, histologic findings alone are not diagnostic.
Optimizing the Use of Topical Agents in Psoriasis
This article briefly addresses key issues that can adversely affect the use of and compliance with currently available topical treatments, as well as new and emerging topical agents for psoriasis.
What Is New in the Treatment of Steroid-Induced Osteoporosis?
Glucocorticoid-induced osteoporosis (GIOP) is a serious complication resulting from longterm steroid treatment.
Methotrexate and Cyclosporine in Psoriasis Revisited
Data on efficacy and adverse effects—particularly hepatoxicity—are reviewed, and recommendations for monitoring are addressed.